Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
The fingerprints are not disease specific, but healthy and diseased fingerprints are remarkably different
Owing to its potential benefits in treating diabetes and off-label use for obese conditions, the molecule will bring cumulative sales of more than USD 100 billion by 2029
Empagliflozins fuel hypothesis: not so soon
The oral versus injection comparison and tablets versus injections analysis can help researchers determine which format best fits their needs
CeVD was defined as at least one of: prior stroke
US$ 27.33
US$ 21.55
US$ 22.03
US$ 29.60
